ZHEJIANG, ZHEJIANG, CHINA, January 21, 2026 /EINPresswire.com/ -- In the interconnected world of 2026, where a ...

The national grid suffered its second collapse in four days on Tuesday, plunging millions into darkness.This is as the Lagos ...

The short digital reset helps people actively navigate job loss using structured, AI-supported preparation. Job loss often requires people to present themselves clearly before they feel ready. This ...

Add Yahoo as a preferred source to see more of our stories on Google. MetaVia's DA-1726 is a dual OXM analogue agonist that functions as a glucagon-like peptide-1 receptor (GLP-1RA) and glucagon ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Altimmune Inc. (NASDAQ: ALT) on Friday shared topline results from the IMPACT Phase 2b trial of pemvidutide. Patients had metabolic dysfunction-associated steatohepatitis (MASH) at 48 weeks. MASH is a ...

Altimmune has shared an update on the metabolic dysfunction-associated steatohepatitis (MASH) study that sank its stock in June. The 48-week readout linked the top dose of the GLP-1/glucagon dual ...

Eli Lilly and Co. on Thursday released Phase 3 trial results for its highly anticipated GLP-1 pill orforglipron, which they said outperformed a placebo when taken for weight-loss maintenance after ...

Sen. Kelda Roys, D-Madison, announced the Pregnancy Loss Protection Act Dec. 2, which would protect those who experience pregnancy loss from prosecution, according to a press release. This bill would ...